A FDA suspende as vendas de vacinas contra a vacina Chikungunya de Valneva nos EUA devido a eventos adversos relatados no exterior. FDA halts Valneva's Chikungunya vaccine sales in U.S. due to adverse events reported abroad.

A FDA suspendeu a vacina Chikungunya de Valneva, IXCHIQ, nos EUA, após quatro novos eventos adversos graves relatados fora do país. The FDA has suspended Valneva's Chikungunya vaccine, IXCHIQ®, in the US following four new serious adverse events reported outside the country. Esta suspensão imediata interrompe todas as remessas e vendas da vacina nos EUA. This immediate suspension halts all shipments and sales of the vaccine in the US. Valneva está investigando os casos e avaliando o impacto financeiro, dada a contribuição da vacina para as vendas. Valneva is investigating the cases and assessing the financial impact, given the vaccine's contribution to sales. A empresa continua comprometida com a disponibilidade global da vacina para a prevenção do surto de chikungunya. The company remains committed to the vaccine's global availability for chikungunya outbreak prevention.